Holen Sie sich die Stockscreener-App
12.35
0.24%
-0.03
Handel nachbörslich:
12.51
0.16
+1.30%
Schlusskurs vom Vortag:
$12.38
Offen:
$12.26
24-Stunden-Volumen:
1.87M
Relative Volume:
0.79
Marktkapitalisierung:
$1.42B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-12.11
EPS:
-1.02
Netto-Cashflow:
$150.93M
1W Leistung:
-18.37%
1M Leistung:
-48.41%
6M Leistung:
-46.47%
1J Leistung:
-57.89%
1-Tages-Spanne:
$12.23
$12.62
1-Wochen-Bereich:
$12.18
$15.56
52-Wochen-Spanne:
$12.18
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| EVH | 12.35 | 1.42B | 2.35B | -74.42M | 150.93M | -1.02 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health (NYSE:EVH) Given New $28.00 Price Target at Oppenheimer - MarketBeat
Royce & Associates LP Invests $7.07 Million in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evolent Health, Inc. to Release Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Wednesday, February 23, 2022 - Quantisnow
Humana and Evolent expand partnership to enhance oncology care - The Cancer Letter
Evolent Health stock hits 52-week low at $12.28 - Investing.com
EVH (Evolent Health) Other Current Assets : $40 Mil (As of Sep. 2024) - GuruFocus.com
Evolent Health's SWOT analysis: stock faces headwinds amid growth potential By Investing.com - Investing.com Nigeria
Evolent Health's SWOT analysis: stock faces headwinds amid growth potential - Investing.com
FMR LLC Adjusts Stake in Evolent Health Inc - GuruFocus.com
Evolent Health Inc (EVH) Shares Down 4.96% on Nov 12 - GuruFocus.com
Royal Bank of Canada Reiterates Outperform Rating for Evolent Health (NYSE:EVH) - MarketBeat
Trading (EVH) With Integrated Risk Controls - Stock Traders Daily
Evolent Health: A Shot At Revival After Market Bruising (NYSE:EVH) - Seeking Alpha
Evolent Health (NYSE:EVH) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Barclays Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Q3 2024 Earnings Call Transcript - Insider Monkey
Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper - Simply Wall St
Evolent Health Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics - MSN
Evolent Health downgraded at Stephens amid surging cancer costs - Yahoo Finance
Evolent Health price target lowered to $20 from $42 at RBC Capital - TipRanks
Evolent Health price target lowered to $36 from $45 at BTIG - TipRanks
Evolent Health stock hits 52-week low at $14.69 amid market shifts - Investing.com India
Evolent Health Inc Class A (EVH) Quarterly 10-Q Report - Quartzy
RSI Alert: Evolent Health (EVH) Now Oversold - Nasdaq
Oppenheimer Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health price target lowered to $27 from $43 at JMP Securities - TipRanks
Hollencrest Capital Management Sells 66,825 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Reaches New 52-Week LowHere's Why - MarketBeat
Evolent Health falls on annual revenue, adjusted profit forecast cut - XM
Cracking The Code: Understanding Analyst Reviews For Evolent Health - Benzinga
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Evolent Health (NYSE:EVH) Lowered to Equal Weight Rating by Stephens - MarketBeat
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms - MSN
Evolent Health Shares Plunge on 3Q Results Miss, Full-Year Outlook Cut - MarketWatch
Evolent Health (EVH) Q3 Earnings and Revenues Lag Estimates - MSN
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navig - GuruFocus.com
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... By GuruFocus - Investing.com Canada
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... - Yahoo Finance
Evolent Health (EVH) Q3 2024 Earnings Call Transcript - AOL
Why Evolent Health (EVH) is Poised to Beat Earnings Estimates Again - MSN
Evolent Health Reports Revenue Growth Amid Challenges - TipRanks
Evolent Health Inc earnings missed by $0.24, revenue fell short of estimates - Investing.com India
Evolent Health: Q3 Earnings Snapshot - Marketscreener.com
Evolent Health Inc Reports Q3 2024 Revenue of $621.4M, Misses Es - GuruFocus.com
Evolent stock tumbles 34% post-market on Q3 report, lowered guidance - MSN
Evolent stock tumbles 34% post-market on Q3 report, lowered guidance (NYSE:EVH) - Seeking Alpha
Humana and Evolent Expand Partnership to Enhance Oncology Care - Marketscreener.com
Evolent Announces Third Quarter 2024 Results - PR Newswire
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH) - Simply Wall St
Unlocking Q3 Potential of Evolent Health (EVH): Exploring Wall Street Estimates for Key Metrics - MSN
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):